The impact of lung function testing (spirometry) on clinical decision making and quality of life in children, a single centre randomised controlled trial (RCT).

Dr Wicharn Boonjindasup0 个研究点目标入组 106 人开始时间: 2019年12月2日最近更新: 2023年1月30日

适应症

试验速览

Research question Does routine spirometry impact on clinical decisions and patient-related outcome measures of children seen in pulmonology clinics? 2. Background information Spirometry is recommended as an adjunct test in many respiratory practice guidelines. However, there is a paucity of high-quality evidence to support the routine use of spirometry in children. 3. Participant characteristics Children able to perform reliable spirometry with parent/guardian in attendance 4. Key results Using spirometry with clinical review significantly altered doctors’ clinical decisions, especially in follow-up schedule and patient education; and improved patient-reported outcome measures. 5. Limitations This is a non-blinded study. The study was undertaken in a specialist children hospital, so data may not be applicable in other settings. In addition, findings are limited to a single timepoint assessment, and could not determine long term outcomes.

•A child with parents/guardians in attendance and able to provide written consent.
•A child aged from 4 to 18 years, who can perform acceptable spirometry
•Parent/guardian that is able to complete QoL questionnaires
•A child whose physician is willing to being part of the LoCQ Study

•Previously enrolled
•Contraindication for spirometry including dyspnoea, pneumothorax, haemoptysis, vital signs instability, lung cyst or bleb, and recent chest/eye surgery (<3 weeks)

发起方

Dr Wicharn Boonjindasup